• 1
    Mulligan AM, O’Malley FP. Papillary lesions of the breast: a review. Adv. Anat. Pathol. 2007; 14; 108119.
  • 2
    Page DL, Salhany KE, Jensen RA, Dupont WD. Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer 1996; 78; 258266.
  • 3
    Tavassoli FA. Pathology of the breast, 2nd edn. Stamford, CT: Appleton and Lange, 1999.
  • 4
    Elston CE, Ellis IO. The breast. Edinburgh: Churchill Livingstone, 1998.
  • 5
    Lewis JT, Hartmann LC, Vierkant RA et al. An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. Am. J. Surg. Pathol. 2006; 30; 665672.
  • 6
    MacGrogan G, Tavassoli FA. Central atypical papillomas of the breast: a clinicopathological study of 119 cases. Virchows Arch. 2003; 443; 609617.
  • 7
    Kraus FT, Neubecker RD. The differential diagnosis of papillary tumors of the breast. Cancer 1962; 15; 444455.
  • 8
    Raju UB, Lee MW, Zarbo RJ, Crissman JD. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms. Mod. Pathol. 1989; 2; 569576.
  • 9
    Papotti M, Eusebi V, Gugliotta P, Bussolati G. Immunohistochemical analysis of benign and malignant papillary lesions of the breast. Am. J. Surg. Pathol. 1983; 7; 451461.
  • 10
    MacGrogan G, Moinfar F, Raju U. Intraductal papillary neoplasms. In TavassoliFA, DevileePD eds. Pathology and genetics: tumours of the breast and female genital organ. Lyon: IARC Press, 2003; 7680.
  • 11
    Collins LC, Carlo VP, Hwang H, Barry TS, Gown AM, Schnitt SJ. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers. Am. J. Surg. Pathol. 2006; 30; 10021007.
  • 12
    Hill CB, Yeh IT. Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas. Am. J. Clin. Pathol. 2005; 123; 3644.
  • 13
    Mulligan AM, O’Malley FP. Metastatic potential of encapsulated (intracystic) papillary carcinoma of the breast: a report of 2 cases with axillary lymph node micrometastases. Int. J. Surg. Pathol. 2007; 15; 143147.
  • 14
    Leal C, Costa I, Fonseca D, Lopes P, Bento MJ, Lopes C. Intracystic (encysted) papillary carcinoma of the breast: a clinical, pathological, and immunohistochemical study. Hum. Pathol. 1998; 29; 10971104.
  • 15
    Lefkowitz M, Lefkowitz W, Wargotz ES. Intraductal (intracystic) papillary carcinoma of the breast and its variants: a clinicopathological study of 77 cases. Hum. Pathol. 1994; 25; 802809.
  • 16
    Harris KP, Faliakou EC, Exon DJ, Nasiri N, Sacks NP, Gui GP. Treatment and outcome of intracystic papillary carcinoma of the breast. Br. J. Surg. 1999; 86; 1274.
  • 17
    Carter D, Orr SL, Merino MJ. Intracystic papillary carcinoma of the breast. After mastectomy, radiotherapy or excisional biopsy alone. Cancer 1983; 52; 1419.
  • 18
    Maluf HM, Koerner FC. Solid papillary carcinoma of the breast. A form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma. Am. J. Surg. Pathol. 1995; 19; 12371244.
  • 19
    Nassar H, Qureshi H, Volkanadsay N, Visscher D. Clinicopathologic analysis of solid papillary carcinoma of the breast and associated invasive carcinomas. Am. J. Surg. Pathol. 2006; 30; 501507.
  • 20
    Rabban JT, Koerner FC, Lerwill MF. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6. Hum. Pathol. 2006; 37; 787793.
  • 21
    Troxell ML, Masek M, Sibley RK. Immunohistochemical staining of papillary breast lesions. Appl. Immunohistochem. Mol. Morphol. 2007; 15; 145153.
  • 22
    Yaziji H, Gown AM, Sneige N. Detection of stromal invasion in breast cancer: the myoepithelial markers. Adv. Anat. Pathol. 2000; 7; 100109.
  • 23
    Liberman L, Bracero N, Vuolo MA et al. Percutaneous large-core biopsy of papillary breast lesions. Am. J. Roentgenol. 1999; 172; 331337.
  • 24
    Philpotts LE, Shaheen NA, Jain KS, Carter D, Lee CH. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Radiology 2000; 216; 831837.
  • 25
    Ioffe OB, Berg WA, Silverberg SG, Simsir A. Analysis of papillary lesions diagnosed on core needle biopsy of the breast: management implications (Meeting Abstract). Mod. Pathol. 2000; 13; 23A.
  • 26
    Mercado CL, Hamele-Bena D, Singer C et al. Papillary lesions of the breast: evaluation with stereotactic directional vacuum-assisted biopsy. Radiology 2001; 221; 650655.
  • 27
    Renshaw AA, Derhagopian RP, Tizol-Blanco DM, Gould EW. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision. Am. J. Clin. Pathol. 2004; 122; 217221.
  • 28
    Mercado CL, Hamele-Bena D, Oken SM, Singer CI, Cangiarella J. Papillary lesions of the breast at percutaneous core-needle biopsy. Radiology 2006; 238; 801808.
  • 29
    Sydnor MK, Wilson JD, Hijaz TA, Massey HD, Shaw de Paredes ES. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy. Radiology 2007; 242; 5862.
  • 30
    Nagi C, Bleiweiss I, Jaffer S. Epithelial displacement in breast lesions: a papillary phenomenon. Arch. Pathol. Lab. Med. 2005; 129; 14651469.